A rabdomized, double blind, placebo controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib after completion of chemotherapy with bevacizumab for the first line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer


Grant Data
Project Title
A rabdomized, double blind, placebo controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib after completion of chemotherapy with bevacizumab for the first line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer
Principal Investigator
Dr Ho, James Chung Man   (Principal investigator)
Co-Investigator(s)
Dr Wang Julie Kwan Ling   (Co-Investigator)
Dr Lam David Chi Leung   (Co-Investigator)
Dr Wong Matthew King Yan   (Co-Investigator)
Duration
25
Start Date
2007-08-21
Completion Date
2009-09-20
Amount
288359
Conference Title
Presentation Title
Keywords
locally advanced NSCLC, recurrent NSCLC, metastatic NSCLC
Discipline
Respiration,Cancer
Panel
Medicine
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2007/2008
Status
On-going